Miracle Ulcerative Colitis Treatment Really Brings Hope
New research points to the usefulness of a new Entyvio drug for Ulcerative Colitis Treatment. Relief may soon be on the way for more than a million Americans who endure from inflammatory bowel diseases and do not acknowledge to or cannot tolerate the side effects of current medications.Research out today by doctors at the University of California San Diego shows that a new drug For Ulcerative Colitis Treatment works competently for both ulcerative colitis and Crohn’s disease, mostly without severe side effects.Doctors described the results in two studies published in The New England Journal of Medicine.
The ulcerative colitis treatment research elaborate 895 patients in 34 countries. More than 1,100 Crohn’s disease patients from 39 countries were also studied. The researchers accompany subjects for one year.That the Ulcerative Colitis Treatment Drug works in two diseases is a great thing,” said lead researcher Dr. William Sandborn in an interview with Healthline. “It’s vry easy for doctors to get experience for the drug, and that knowledge and experience really translates into better patient care. You need the knowledge quicker, and I think that’s exciting.”Takeda Pharmaceuticals funded the research and filed for U.S. Food and Drug Administration approval of the drug.
Why This Ulcerative Colitis Treatment Drug Is Different
The mechanism of action for new Drug is different from other drugs used for ulcerative colitis treatment. The new drug, known as a leukocyte traffic inhibitor, prevents white blood cells from gathering in the area of inflammation. It specifically targets the gut, leading to fewer infections than immunosupression drugs, which dampen the response of the entire immune system.Those who suffer from inflammatory bowel diseases experience dificulties like diarrhea and a nagging urge to defecate.
The conditions can lead to serious complications, such as intestinal bleeding, colon cancer, and bowel obstructions. Sometimes, a portion of the bowel needs to be removed to bring ulcerative colitis patients relief.Some existing drugs used for the Ulcerative Colitis Treatment do not work for Crohn’s patients.Others cause a serious, often fatal brain disease called progressive multifocal leukoencephalitis (PML).In both studies, about half of the subjects had failed other therapies, Sandborn said.In many cases, study participants with ulcerative colitis experienced complete healing of the bowel.However, five people in the Crohn’s disease study died during the trial.